The Elimination Of A Patent Licensing “Safe Haven”

Law360, New York (April 2, 2007, 12:00 AM EDT) -- In SanDisk, the Federal Circuit applied the Supreme Court’s MedImmune decision (MedImmune Inc. v. Genentech Inc., 127 S. Ct. 764, 166 L. Ed. 2d 604 (2007)) to patent licensing negotiations, and effected “a sweeping change in [Federal Circuit] law regarding declaratory judgment jurisdiction” with potentially “no practical stopping point short of allowing declaratory judgment actions in virtually any case in which the recipient of an invitation to take a patent license elects to dispute the need for a license and then to sue the patentee.” SanDisk...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.